186 related articles for article (PubMed ID: 25008235)
1. The Bologna criteria for the definition of poor ovarian responders: is there a need for revision?
Ferraretti AP; Gianaroli L
Hum Reprod; 2014 Sep; 29(9):1842-5. PubMed ID: 25008235
[TBL] [Abstract][Full Text] [Related]
2. Implementing the ESHRE 'poor responder' criteria in research studies: methodological implications.
Papathanasiou A
Hum Reprod; 2014 Sep; 29(9):1835-8. PubMed ID: 24916434
[TBL] [Abstract][Full Text] [Related]
3. The Bologna criteria for poor ovarian response: the good, the bad and the way forward.
Venetis CA
Hum Reprod; 2014 Sep; 29(9):1839-41. PubMed ID: 24908672
[TBL] [Abstract][Full Text] [Related]
4. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.
Polyzos NP; Blockeel C; Verpoest W; De Vos M; Stoop D; Vloeberghs V; Camus M; Devroey P; Tournaye H
Hum Reprod; 2012 Dec; 27(12):3481-6. PubMed ID: 22940767
[TBL] [Abstract][Full Text] [Related]
5. Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI.
Polyzos NP; Nwoye M; Corona R; Blockeel C; Stoop D; Haentjens P; Camus M; Tournaye H
Reprod Biomed Online; 2014 Apr; 28(4):469-74. PubMed ID: 24581984
[TBL] [Abstract][Full Text] [Related]
6. Prognosis and cost-effectiveness of IVF in poor responders according to the Bologna Criteria.
Busnelli A; Somigliana E
Minerva Ginecol; 2018 Feb; 70(1):89-98. PubMed ID: 28895678
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?
Polyzos NP; Devroey P
Fertil Steril; 2011 Nov; 96(5):1058-61.e7. PubMed ID: 22036048
[TBL] [Abstract][Full Text] [Related]
8. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria.
Ferraretti AP; La Marca A; Fauser BC; Tarlatzis B; Nargund G; Gianaroli L;
Hum Reprod; 2011 Jul; 26(7):1616-24. PubMed ID: 21505041
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
Pu D; Wu J; Liu J
Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
[TBL] [Abstract][Full Text] [Related]
10. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
[TBL] [Abstract][Full Text] [Related]
11. Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study.
La Marca A; Grisendi V; Giulini S; Sighinolfi G; Tirelli A; Argento C; Re C; Tagliasacchi D; Marsella T; Sunkara SK
J Assist Reprod Genet; 2015 Jun; 32(6):931-7. PubMed ID: 25925345
[TBL] [Abstract][Full Text] [Related]
12. Novel Physiology and Definition of Poor Ovarian Response; Clinical Recommendations.
Abu-Musa A; Haahr T; Humaidan P
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204404
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
[TBL] [Abstract][Full Text] [Related]
14. Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization.
Wei Z; Cheng X; Li H; Cao Y; Cong L; Zhou P; Li J
Reprod Biol Endocrinol; 2010 Mar; 8():26. PubMed ID: 20236519
[TBL] [Abstract][Full Text] [Related]
15. Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study.
Polyzos NP; De Vos M; Corona R; Vloeberghs V; Ortega-Hrepich C; Stoop D; Tournaye H
Hum Reprod; 2013 May; 28(5):1254-60. PubMed ID: 23442756
[TBL] [Abstract][Full Text] [Related]
16. Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders.
Kadoch IJ; Phillips SJ; Bissonnette F
Fertil Steril; 2011 Nov; 96(5):1066-8. PubMed ID: 22036050
[TBL] [Abstract][Full Text] [Related]
17. Assessment of theca cell function: a prerequisite to androgen or luteinizing hormone supplementation in poor responders.
Hugues JN; Massart P; Cedrin-Durnerin I
Fertil Steril; 2013 Feb; 99(2):333-6. PubMed ID: 23058685
[TBL] [Abstract][Full Text] [Related]
18. The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization.
Kwee J; Schats R; McDonnell J; Schoemaker J; Lambalk CB
Fertil Steril; 2006 Jun; 85(6):1714-22. PubMed ID: 16650416
[TBL] [Abstract][Full Text] [Related]
19. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.
Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Baart EB; Hohmann FP; Fauser BC; Broekmans FJ
Hum Reprod Update; 2009; 15(1):5-12. PubMed ID: 19091754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]